Study provides personalized strategies to boost AIAA compliance in breast cancer pati

[News]

Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.

More... (http://www.news-medical.net/news/20100603/Study-provides-personalized-strategies-to-boost-AIAA-compliance-in-breast-cancer-patients.aspx)